Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012–2020 is a dataset published in Infectious Diseases of Poverty (2021). On theSindex it has a DataRank of 2.0, placing it in the top 10.7% of the data-sharing corpus. It has been cited 66 times, with 52 citing works in its 1-hop citation network. Its calibrated FAIR score is 6/100.
Ranks in the top 11% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
“Please contact author for data requests.”
The paper does not provide any persistent identifier for its own dataset.
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“Please contact author for data requests.”
The paper does not name a repository; it directs data requests to the author.
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
“Please contact author for data requests.”
No identifier for the dataset appears anywhere in the paper, including in the reference list or body text. [majority verdict 'no' (4/5 passes agreed)]
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“Please contact author for data requests.”
The data-availability statement points to the author, which is Colavizza category 1 (available on request).
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“We assembled three datasets: (1) a list of individual human cases worldwide with demographic, exposure and clinical information, (2) eco-geographic and socioeconomic characteristics (referred to as socioenvironmental variables hereinafter) at the appropriate administrative level in the Middle East (county for Saudi Arabia and province for the other countries), and (3) full-genome sequences of MERS-CoV worldwide.”— not found in the paper; verdict downgraded
The paper describes the datasets in running prose but does not provide an itemised inventory of files or variables. [downgraded to 'no' — no verifiable quote from the paper]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“Please contact author for data requests.”
The only access route is a discretionary request to the author, which is not a followable or unconditional route.
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“Please contact author for data requests.”
The paper gives no explicit access-level label for the data; it only states that the data are available by contacting the author. [majority verdict 'no' (3/5 passes agreed)]
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“Please contact author for data requests.”
The data are human subject data, but the paper names the corresponding author as the gatekeeper, which is a natural person. [majority verdict 'partial' (3/5 passes agreed)]
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
The paper does not state any timeline for data availability or retention period.
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format is named for the released data.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
No data or metadata community standard is named for the study's own dataset.
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
“GenBank accession ID: NC_019843.3”— not found in the paper; verdict downgraded
The paper provides an identifier for a reference genome used in the analysis. [downgraded to 'no' — no verifiable quote from the paper]
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No licence for the data is named; the CC-BY licence applies to the article only. [majority verdict 'no' (4/5 passes agreed)]
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
“MERS cases reported globally as of June 2020”
The paper provides a date (June 2020) as a snapshot reference for the data. [majority verdict 'partial' (3/5 passes agreed)]
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
No code availability is mentioned in the paper.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“R01 AI139761”
The paper provides specific grant numbers from the funders.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
The data were assembled from existing sources; no specific instruments, kits, or software used to produce the dataset are named. [majority verdict 'no' (2/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“A valid record of MERS case must include the basic demographic information (gender, age, reporting country, city of residence, being healthcare worker or not, baseline chronic conditions), dates of critical events (such as symptom onset, first hospitalization, laboratory confirmation), and exposure information (whether exposed to animal or its raw production, or exposed to confirmed MERS patients).”— not found in the paper; verdict downgraded
The variable definitions are provided inside the article in the methods section, not as a separate documentation object. [downgraded to 'no' — no verifiable quote from the paper]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.631
From this paper's citation signal
Citation Network Contribution
1.4
From 43 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 52 citers.
China Mega-Project on Infectious Disease Prevention
Grant: 2017ZX10303401
China Mega-Project on Infectious Disease Prevention
Grant: 2018ZX10713002
China Mega-Project on Infectious Disease Prevention
Grant: 2018ZX10101003
China Mega-Project on Infectious Disease Prevention
Grant: 2018ZX10201001
National Natural Science Foundation of China
Grant: 81825019
the National Institutes of Health of United States
Grant: R01 AI139761
the National Institutes of Health of United States
Grant: R56 AI148284
NIAID NIH HHS
Grant: R01 AI116770
National Institutes of Health
Grant: 5R01AI139761-05
Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats
National Institutes of Health
Grant: 7R01AI116770-03
Regression, Phylogenetics, and Study Design in Infectious Disease Epidemiology
National Institutes of Health
Grant: 1R56AI148284-01A1
Mathematical and Statistical Methods for the Control of Global Infectious Disease Threats
Influential Citations
5
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012–2020
Additional file 1 of Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012–2020
Additional file 1 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 1 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 2 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 3 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 2 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 3 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 6 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 5 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 5 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 6 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 4 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
Additional file 4 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein